MetaDolce Technologies Named Authorized U.S. Reseller by Richtech Robotics

MetaDolce Technologies, Inc. (“MetaDolce Technologies”) this week was named an authorized U.S. reseller by Richtech Robotics Inc. (Nasdaq: RR) (“Richtech”). Recently, Richtech, a Nevada-based provider of AI-driven service robots, introduced Medbot: a new elevator-enabled robot designed to enhance pharmacy and hospital operations with uninterrupted medical delivery. MetaDolce Technologies, through its servicerobotics.ai website, will co-market and sell Medbot along with Richtech throughout the United States, with product placements expected to begin in the second quarter of 2024.

“As the wave of robotics innovation continues worldwide, perhaps the most natural fit for automated package delivery is in medical services,” said Mr. Moshe Meppen, President & CEO, MetaDolce Technologies. “Richtech’s new delivery robot, Medbot, is ideal for this role: providing elevator-enabled 24/7 medical delivery that is self-running, and secure using ‘Chain of Custody’ tracking technology. We look forward to working with Richtech to launch and sell Medbot, as well as other solutions from Richtech’s extensive product catalog.”

“With our track record of success across hospitality and service sectors, producing a delivery solution for the healthcare industry was a natural progression,” said Matt Casella, President of Richtech. We’re equally excited about our new reseller partnership with MetaDolce Technologies, who will assist us going forward in launching and placing the Medbot medical delivery robot in pharmacy and medical operations throughout the United States.”

Medbot Medical Delivery Robot

With the healthcare industry facing hospital and pharmacy staff shortages, Richtech’s Medbot enables hospitals and clinics to automate medical deliveries with reliable, secure, and uninterrupted service. Working up to 24 hours (10 hours continuously), Medbot makes secure deliveries to patients with high accuracy, allowing pharmacies to reallocate labor resources to more value-add tasks. To date, Medbot has been used in pharmacy to in-patient units and emergency departments, chemotherapy preparations to infusion centers, pharmacy-to-pharmacy/intra-pharmacy transport, and “meds-to-beds” discharge medications from outpatient pharmacy to the patient’s nurse.

About Richtech

Richtech is a provider of collaborative robotic solutions specializing in the service industry, including hospitality and healthcare sectors. Richtech’s mission is to transform the service industry through collaborative robotic solutions that enhance the customer experience and empower businesses to achieve more. By seamlessly integrating cutting-edge automation, Richtech aspires to create a landscape of enhanced interactions, efficiency, and innovation, propelling organizations toward unparalleled levels of excellence and satisfaction. See more at https://www.richtechrobotics.com.

About MetaDolce Technologies

MetaDolce Technologies provides best-in-class robotic, biometric, and mobile data capture products and integrated solutions to commercial, enterprise, and government organizations worldwide. Its solutions are specifically designed for automation, authentication, access control, law enforcement, border protection, time & attendance, transportation, hospitality and healthcare applications. Learn more at https://www.metadolcetechnologies.com.

Forward Looking Statements

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “anticipate,” “believe,” “forecast,” “estimate,” “expect,” and “intend,” among others. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties.

These forward-looking statements are based on Richtech’ current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, the success of the Richtech’s partnership with MetaDolce Technologies, the ability of Richtech and MetaDolce Technologies to begin product placements in the second quarter of 2024, Medbot’s ability to provide reliable, secure, and uninterrupted service and maintain its delivery success rate. Investors should read the risk factors set forth in Richtech’ Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the “SEC”) on January 11, 2024 and periodic reports filed with the SEC on or after the date thereof. All of Richtech’ forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date thereof. New risks and uncertainties arise over time, and it is not possible for Richtech to predict those events or how they may affect Richtech. If a change to the events and circumstances reflected in Richtech’ forward-looking statements occurs, Richtech’ business, financial condition and operating results may vary materially from those expressed in Richtech’ forward-looking statements.

Readers are cautioned not to put undue reliance on forward-looking statements, and Richtech assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240529948533/en/